antibrca1 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
antibrca1
Antibrca1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 416 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibrca1/BRCA1+Antibody/pm41197758-76-14-16
Average 96 stars, based on 416 article reviews
Antibrca1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 416 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antibrca1/BRCA1+Antibody/pm41197758-76-14-16
Average 96 stars, based on 416 article reviews
antibrca1 - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Western Blot:Article Title: MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer Cells Article Snippet: .. Lysates were subjected to immunoblotting with anti-MUC1-C (HM-1630-P1ABX; Thermo Fisher Scientific), anti--actin (A5441; Sigma), anti-lamin A/C (4777), anti-H2AX (9718), anti-ATR (2790), anti-pCHK1 (2348), anti-CHK1 (2360), anti-pBRCA1 (9009), Article Title: Berberine overcomes paclitaxel resistance in Triple-Negative Breast Cancer by inhibiting HSP90-mediated BRCA1 phosphorylation. Article Snippet: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer, and chemotherapy remains a major component of the standard therapy.. Although there is an initial response, the tumor will inevitably develop resistance to paclitaxel (PTX) treatment.. Berberine (BBR) exhibits excellent anti-cancer activity in a variety of tumor cells and drug-resistant tumor cells. other:Article Title: Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression. Article Snippet: Aim: The BRCA1 promoter is hypermethylated in ovarian cancer patients.. We postulated that this hypermethylation might be involved in ovarian cancer progression.. Methods: To confirm our hypothesis, tissue and serum samples were collected from ovarian carcinoma patients and categorized according to tumor stage. |